Skip to content

Virtual Patent Marking

The Splanchnic Ablation for Volume Management (SAVM) procedure, Satera™ Ablation System or their use are protected by one or more of the following patents in the United States and/or in other jurisdictions of the world. This webpage is provided to satisfy the virtual patent marking provisions of various jurisdictions, including the virtual patent marking provisions of the America Invents Act and to provide notice under 35 U.S.C. § 287(a). 

Further, the following list of products and services may not be all inclusive, and other Axon Therapies products and services not listed here may be protected by one or more patents in the United States and elsewhere. Additional patent applications may be pending in the United States and elsewhere.

Patents

US 10,376,308
US 10,912,610

Updated: December 29, 2022

The Axon Ablation System is an investigational device and is not currently approved for clinical use in any geography.

CAUTION – Investigational Device. Limited by Federal (or United States) law to Investigational Use.

 ClinicalTrials.gov identifier:  NCT04592445

©2022 Axon Therapies Inc. All rights reserved. Axon is a trademark of Axon Therapies, Inc.
Patent information